Simon Nicholas
SEC-identified person · CIK 1431403 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Sientra, Inc. SIEN | Director | filed 2014 - 2021 |
| Gritstone bio, Inc. GRTS | Director | filed 2018 - 2020 |
| Entasis Therapeutics Holdings Inc. [ETTX] | Officer | filed 2018 - 2018 |
| Forty Seven, Inc. FTSV | Officer | filed 2018 - 2018 |
| Venus Concept Inc. VERO | Officer | filed 2017 - 2017 |
| Tetralogic Pharmaceuticals Corp TLOG | Officer | filed 2013 - 2016 |
| Oxford Immunotec Global PLC OXFD | Officer | filed 2013 - 2015 |
| Ophthotech Corp. OPHT | Officer | filed 2013 - 2015 |
| Aerie Pharmaceuticals INC AERI | Officer | filed 2013 - 2015 |
| Globus Medical INC GMED | Officer | filed 2012 - 2013 |
| Achillion Pharmaceuticals INC ACHN | Director | filed 2008 - 2012 |
| Zogenix, INC. ZGNX | Officer | filed 2010 - 2011 |
| Avanir Pharmaceuticals, INC. AVNR | Officer | filed 2008 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.